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Abstract
Wall materials play a vital role in the development of micro-/nanocapsules to protect 
the bioactive compounds against external factors. The encapsulation process and the 
type of polymers exert a direct impact on the development of bioactive micro-/nano-
capsules, which greatly reflect in encapsulation efficiency, solubility, stability, surface 
permeability, and release profile of desired bioactive compounds. Among the polymers, 
biodegradable polymeric materials have been the focus for various applications in 
food, pharmaceutical, and cosmetic industries. Thus, this chapter focuses on different 
encapsulation techniques and the importance of biodegradable polymers employed as 
wall materials for developing stable and safe micro-/nanocapsules. Among the natural 
polymers, protein- and polysaccharide-based polymers are widely used. Similarly, the 
most commonly used synthetic polymers are polycaprolactone, poly(lactic-co-glycolic 
acid), and polyethylene glycol. Synthetic polymers have been classified based on their 
exogenous and endogenous responsive natures. At the end, we have also discussed on 
the applications of biodegradable polymers employed in the development of micro-/
nanocapsules. To compile this chapter and to provide adequate information to the 
readers, we have explored various sources, such as reviews, research articles, books, and 
book chapters including Google sites.
Keywords: biodegradable polymers, microcapsules, nanocapsules, responsive 
polymers
1. Introduction
Encapsulation is a process in which tiny particles or droplets are surrounded by 
a coating to form capsules. Microcapsules and nanocapsules are small spheres with 
a uniform wall around it. The material inside the capsule is referred as the core, 
internal phase, or fill, whereas the wall is called as the shell, coating, or membrane. 
The core material may be liquid or solid, active constituents, stabilizers, diluents, 
excipients, and release-rate retardants or accelerators.
Encapsulation can be done for multiple reasons. The primary purpose of encap-
sulation is either for sustained or prolonged drug release. For orally delivered drugs, 
this method has been widely used for masking taste and odor to improve patient 
compliance, reduce toxicity, and gastrointestinal irritation. This method can be 
used to convert liquid drugs to a free flowing powder form, prevent vaporization of 
volatile drugs, alter the site of absorption, and to prevent incompatibility among the 
drugs. The drugs which are sensitive to oxygen, moisture, light, or pH changes can 
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be stabilized by encapsulation. Depending on the applications, the wall material of 
the capsules is designed to serve the desired specific purpose.
Thus, the wall material is the most vital component in any capsule. The 
selection of appropriate wall material decides the physical and chemical proper-
ties of the resultant micro-/nanocapsules. The wall material should have the 
properties like being inert toward core active ingredients, stabilize the core 
material, film-forming, pliable and tasteless, non-hygroscopic, moderate viscos-
ity, economical and soluble in an aqueous media or solvent, or melting, the 
coating may be flexible, brittle, hard, and thin, controlled release at the specific 
site under specific conditions.
Understanding the importance of polymers as wall materials, we have 
attempted to give a review of wall materials used in micro- and nanocapsules 
for the sustained/controlled delivery of drugs. A detailed account on encap-
sulation techniques is given. The biodegradable materials employed as wall 
materials are discussed adequately. The advantages of biodegradable materials 
including their limitations are covered in the chapter. The release profiles were 
discussed based on both exogenous and endogenous responsiveness of the wall 
materials. At the end of the chapter, future prospects and challenges of the wall 
materials are highlighted.
2. Encapsulation techniques
Microencapsulation of active compounds can be achieved by physical and 
chemical methods. Though these techniques are neither purely physical nor purely 
chemical, they are classified as physical and chemical methods based on the pre-
dominant or primary principle involved. In Table 1, we have listed commonly used 
physical and chemical methods used for encapsulation.
3. Polymers as wall materials
3.1 Natural polymers
Natural polymers are broadly classified into protein-based polymers and 
polysaccharide-based polymers. Albumin and gelatin are the examples of protein-
based polymers. Polysaccharide-based polymers are agarose, alginate, hyaluronic 
acid, dextran, chitosan, etc. These natural polymers are highly biodegradable and 
biocompatible in nature.
Physical methods Chemical methods
Air suspension coating Solvent evaporation
Coacervation Polymerization
Centrifugal extrusion
Pan coating
Spray drying
Fluidized bed technology
Table 1. 
Encapsulation techniques.
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3.1.1 Protein-based polymers
3.1.1.1 Albumin
Albumin is a biodegradable and water soluble protein and thus plays an impor-
tant role in the circulating system. It is involved in osmotic pressure regulation, 
binding, and transport of nutrients to the cells that can be obtained from a variety 
of sources including egg white, bovine serum, and human serum. It is stable in 
the pH range of 4–9 and can be heated at 60°C up to 10 h without any deleterious 
effects [1]. It undergoes degradation by protease enzymes, which helps the micro-
capsules to release the drugs in the small intestine. It also facilitates the release of 
therapeutic cargo from nanocapsules inside the endosomes.
3.1.1.2 Gelatin
Gelatin is biodegradable, inexpensive, easily sterilized, non-pyrogenic, non-
toxic, non-immunogenic, and easy to be crosslinked or modified chemically. 
Gelatin has many ionizable groups, such as carboxyl, amino, phenol, guanidine, 
and imidazole, which are potential sites for conjugation or chemical modifica-
tions. Chemical crosslinking agents like glutaraldehyde improves the integrity and 
performance of the gelatin and provides gelatin with greater stability, shape, and 
increased circulation time in vivo [2]. The degree of crosslinking determines the 
release of drugs from the gelatin capsules. Thus, gelatin is regarded as a safe excipi-
ent approved by the US FDA for pharmaceutical applications.
3.1.2 Polysaccharide-based polymers
3.1.2.1 Chitosan
Chitosan, the second most abundant polysaccharide in nature, is a promising 
biopolymer widely used in biomedical and pharmaceutical fields like wound dressing, 
tissue engineering and drug delivery. It is produced from chitin which is the structural 
element found in the exoskeleton of crustaceans like shrimps, lobsters, and crabs. 
Chitosan has been reported to exhibit many therapeutic properties, such as activation 
of immune response, cholesterol lowering activity, anti-hypertensive activity, inhibi-
tion of growth of microorganism, pain alleviation, and promotion of hemostasis and 
epidermal cell growth [3]. This is all due to the favorable pharmaceutical properties of 
chitosan, such as biocompatibility, low production cost, ability to bind some organic 
compounds, susceptibility to enzymatic hydrolysis, and nontoxicity.
Chitosan is considered as the most important polysaccharide-based polymer 
owing to its cationic character based on its primary amino groups, which are 
responsible for its versatile properties, such as mucoadhesion (improves pulmonary 
drug delivery), controlled drug release, transfection, in situ gelation, and efflux 
pump inhibitory properties and permeation enhancement [4]. The major drawback 
is its poor solubility at physiological pH due to partial protonation of the amino 
groups in the presence of proteolytic enzymes and thereby causing presystemic 
metabolism of drugs in intestinal and gastric fluids. To overcome these inherent 
drawbacks, various derivatives of chitosan, such as carboxylated, different conju-
gates, thiolated and acylated chitosan have been used in drug-delivery systems [3].
Chitosan is produced by the deacetylation of chitin. The degree of deacetylation 
is related to chitosan’s crystallinity and degradation rates. Chitosan’s solubility can 
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also be improved when the primary amino group is protonated at low pH. The vis-
cosity of chitosan solution increases with increasing the concentration of chitosan 
[5]. These properties and the ease with which it can be modified makes chitosan a 
versatile and bioactive polymer for its use in encapsulation.
3.1.2.2 Hyaluronic acid
Hyaluronic acid (HA) is a nonsulfated glycosaminoglycan, comprising a rela-
tively simple linear structure of alternating units of D-glucuronic acid and N-acetyl-
D-glucosamine, linked via β-1,3- and β-1,4-glycosidic bonds. Hyaluronic acid is 
biodegradable, biocompatible, nontoxic, and non-immunogenic glycosaminoglycan 
distributed widely in connective, epithelial, and neural tissues.
The cluster of differentiation (CD) protein CD44 is the main HA binding 
receptor. CD44 is involved in the interaction between HA and the surface of 
specific cells, in cell proliferation, in cellular adhesion processes (aggregation and 
migration), angiogenesis, in cell survival and endocytosis of HA. CD44 receptor 
is also overexpressed in many types of tumors and this overexpression is related 
to tumor invasion and tumor metastasis, which makes HA a promising candidate 
for intracellular delivery of imaging and anticancer agents exploiting a receptor-
mediated active targeting strategy. HA also interacts with hyaluronan receptor for 
endocytosis (HARE), lymphatic vessel endothelium receptor-1 (LYVE-1), and 
intracellular adhesion molecule-1 (ICAM-1), serum-derived hyaluronan-associated 
protein (SHAP), Brevican and Neurocan (brain and nervous tissue-specific HA 
and proteoglycan binding proteins), hyaluronan-binding protein 1 (HABP1) and 
toll-like receptors (TLRs), and all of which have specific functions. This is known 
as receptor-ligand interaction, which can be exploited to achieve receptor-mediated 
active targeting strategy [6, 7]. HA has been bioconjugated with anticancer drugs, 
like paclitaxel, doxorubicin, cisplatin, etc. and anti-inflammatory drugs like metho-
trexate, dexamethasone, methylprednisolone, etc. to achieve receptor-mediated 
endocytosis [8]. HA polymer has also been used in the treatment of osteoarthritis, 
in ocular and plastic surgery, and in tissue engineering.
3.2 Synthetic polymers
Over the past 5–6 decades, biodegradable polymers have gained tremendous atten-
tion due to their growing applications in biomaterials, drug-delivery systems, tissue 
engineering, and medical devices. Chemists, biologists, physicians, and engineers 
have collaboratively made significant advancements in these applications. The most 
commonly used synthetic polymers in micro-/nanocapsules for drug-delivery applica-
tions are poly(Ɛ-caprolactone), poly(lactic-co-glycolic acid), and polyethylene glycol.
3.2.1 Poly(Ɛ-caprolactone)
Poly(Ɛ-caprolactone) (PCL) is a semicrystalline aliphatic polyester with glass 
transition temperature and melting temperature of about −60 and 60°C, respec-
tively [9]. PCL mixes well with other polymers to form blends that impart good 
physical and chemical properties to achieve desired properties like swelling, poros-
ity, and stability in different media. Microcapsulation or nanocapsulation with PCL 
has many advantages like modulation of drug release, control of drug penetration/
permeation into the skin, and improve photochemical stability and pharmacologi-
cal response. Due to its long degradation times, PCL has found many applications in 
tissue engineering and prolonged drug release. PCL is approved by the US Food and 
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Drug Administration (FDA) and has found numerous applications in implants and 
surgical absorbable sutures due to its biocompatibility and slow biodegradability.
3.2.2 Poly(lactic-co-glycolic acid)
Poly(lactic-co-glycolic acid) (PLGA) is the most extensively studied degradable 
polymer to date. PLGA is an aliphatic polyester and it undergoes hydrolysis in the 
body to produce biodegradable metabolite monomers such as lactic acid and glycolic 
acid. During metabolism in the body via the Krebs cycle, carbon dioxide, and water 
are removed and thereby toxicity is minimized [10]. PLGA is approved by the US 
FDA for use in drug-delivery systems due to its biodegradability with tissue and 
cells, drug biocompatibility, suitable biodegradation kinetics, mechanical proper-
ties, and ease of processing. Thus, PLGA based microcapsules and nanocapsules 
are the most viable candidates for drug-delivery systems, anticancer agents, bio-
imaging, and vaccine immunotherapy.
3.2.3 Poly(ethylene glycol)
Polyethylene glycol (PEG) is also the most widely used “stealth” polymer in 
drug delivery. It is approved by the US FDA and considered to be safe. Coating of 
nanocapsules with PEG generates a hydration layer due to its hydrophilic nature and 
forms a steric barrier. This steric hindrance effect helps the nanocapsules to avoid 
interactions with neighboring capsules and blood components like immunogenic 
cells [11]. PEG coating on nanocapsules shields it from aggregation, opsoniza-
tion, and phagocytosis by reticuloendothelial system. The lack of immunogenicity 
confers PEG-coated nanocapsules with prolonged systemic circulation time which 
in turn leads to enhance absorption due to enhanced permeation and retention 
effect. PEGylation has become a mainstay in fabrication of drug-delivery systems 
that require high doses of toxic drugs with prolonged duration of action.
4. Sensitive polymers
The design of polymeric drug-delivery systems has matured to exploit local 
biochemical changes in pathological states to trigger drug release. In a classical 
example, organs or tissues with cancer are characterized by a shift in homeostasis 
which include, but are not limited to, surge in specific enzymatic activity, shift 
toward acidic pH, reductive or oxidative states, or a buildup of reactive oxygen 
species. These homeostatic disturbances can be exploited for the development of 
targeted therapies that can be activated under certain conditions to trigger drug 
release. Being aware of these intracellular and extracellular changes allows us to 
design smart polymer microcapsules and nanocapsules. In addition to these homeo-
static disturbances, external physical parameters, such as temperature, ultraviolet 
light, ultrasound, or magnetic energy, can also be used to trigger drug release from 
polymer capsules. Thus, in this chapter, we have attempted to summarize the effects 
of adding biologically responsive moieties to the polymer structure in order to 
achieve more targeted controlled therapeutic outcomes. They are exogenous and 
endogenous factors.
4.1 Exogenous factors
Exogenous stimuli result in manipulation of capsule structure from outside the 
body, such as heat, light, or ultrasound induction.
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4.1.1 Temperature sensitive
Temperature sensitive polymeric capsules have been designed to release the drug 
payloads at the target site due to an induced change in temperature acting as a trigger. 
The polymers are selected or designed so as to change their physical and chemical 
properties in response to temperature change. Most tumors and inflammatory condi-
tions tend to exhibit a localized rise in temperature as a result of increased blood 
flow due to vasodilation or angiogenesis, leukocytic infiltration, increased metabolic 
activity, and increased cell proliferation and high cell turnover in pathological 
tissues. Besides this inherent temperature differential between healthy and diseased 
tissue, external sources can be employed to induce a localized temperature change.
Polymers have been discovered that undergo conformational changes upon 
temperature variation. These conformational changes could result from a change 
in hydration states. A majority of temperature sensitive polymers are hydrophilic 
below a certain temperature and are hydrophobic above a specific temperature. 
The temperature at which this phase transition occurs is called the lower critical 
solution temperature (LCST) [12]. The temperature range at which the capsule 
releases the cargo can be tuned by modulating the balance between hydrophilic 
and hydrophobic groups in the polymer. It is desirable for a temperature-sensitive 
capsule to release its cargo at a temperature range of 37–42°C. It is considered to be 
the optimum working range to attain maximum physiological benefit without any 
toxic affects due to protein denaturation above 42°C.
Poly(N-isopropylacrylamide) (PNIPAAm) is the most extensively investigated 
temperature sensitive polymer. It exhibits a LCST of approximately 33°C in aqueous 
solution, below which PNIPAAm is water soluble and above which it becomes water 
insoluble. The LCST of PNIPAAm-based polymers can be tuned by copolymeriza-
tion with hydrophilic or hydrophobic moieties. Incorporation of hydrophilic moi-
eties increases the LCST of the resultant PNIPAAm copolymer and incorporating a 
hydrophobic moiety would decrease the LCST [13]. However, questions still linger 
over the biocompatibility of PNIPAAm, which make it an unsavory choice based on 
the known neurotoxicity of acrylamide monomer and the hydrolysis of PNIPAAm 
under acidic condition, which yield highly toxic amine molecules [14].
Poly(N-vinylcaprolactam) (PNVCL) is a temperature sensitive polymer that 
provides a favorable alternative. In contrast to PNIPAAm, PNVCL is biocompatible 
with extremely low cytotoxicity and does not release toxic small organic amine 
compounds upon hydrolysis. PNVCL was well tolerated with the Caco-2 and Calu-3 
cell lines up to 10 mg mL−1. Further in vivo studies are needed to study organ 
toxicity and elimination to give an in-depth evaluation on its potential. PNVCL-
containing materials have been scrutinized for cell immobilization, tissue engineer-
ing, anticancer drug delivery, protein separation, etc.
Aliphatic polyesters are attractive thermoresponsive biocompatible and 
degradable materials for the development of nanocapsules. Ɛ-Caprolactones 
are biocompatible temperature-sensitive aliphatic polyesters that exhibit a slow 
biodegradability profile. Cheng et al. [15] synthesized a thermoresponsive poly 
{γ-2-[2-(2-methoxyethoxy)-ethoxy]ethoxy-Ɛ-caprolactone}-b-poly(γ-octyloxy-Ɛ-
caprolactone) (PMEEECL-b-POCTCL) diblock copolymer with a LCST of 38°C. It 
combined the biocompatibility and biodegradability properties of polycaprolac-
tone with the thermo-responsive properties of oligoethylene glycol-substituted 
polymers. The thermally sensitive diblock copolymer PMEEECL-b-POCTCL 
was able to sense the elevated local temperature due to faster metabolism or 
induced hyperthermia and then release Nile Red and Doxorubicin in a controlled 
manner (Figures 1 and 2). The PMEEECL-b-POCTCL block copolymer also 
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showed relatively low cytotoxicity. Rainbolt et al. [16] synthesized amphiphilic 
diblock copolymers comprising poly[γ-(2-methoxyethoxy)-Ɛ-caprolactone] and 
thermosensitive poly{γ-2-[2-(2-methoxyethoxy)ethoxy]ethoxy-Ɛ-caprolactone} 
(PMECL) as the hydrophobic and hydrophilic blocks, respectively. By controlling 
the ratio between the monomers MEEECL and MECL, and by varying the number 
of pendant ethylene oxide units, they were able to achieve highly tunable LCSTs 
in the range of 31–43°C. PMEEECL-b-PMECL copolymers possessed fully biode-
gradable backbones. The fundamental lack of chemical functionality in the parent 
aliphatic polyesters makes it difficult to modify the polymer backbone.
Aliphatic polycarbonates have been employed to produce thermoresponsive bio-
compatible and degradable materials. Kim et al. [17] synthesized thermoresponsive 
block copolymers by the ring opening polymerization of cyclic carbonate monomers 
Figure 1. 
(A) CLSM images of MCF-7 cells treated with DOX-loaded PMEEECL-b-POCTCL micelles at either 37 
(below LCST) or 40°C (above LCST) for 24 h. For each panel, images from left to right show cells with DOX 
(red fluorescence), DAPI (blue fluorescence), and overlays of both images. The scale bar indicates 20 μm. (B) The 
viability of MCF-7 cells incubated with various concentrations of DOX-loaded PMEEECL-b-POCTCL micelles 
and free DOX at either 37 or 40°C after 24 h of incubation (n = 6). * and # indicate a significant difference 
between the two participating groups (p < 0.05). Reprinted with permission from Ref. [8]. Copyright 2012 
American Chemical Society.
Figure 2. 
Cumulative Nile Red release from PMEEECL-b-POCTCL micelle at room temperature, 37 (below LCST) and 
40°C (above LCST) in PBS. Reprinted with permission from Ref. [8]. Copyright 2012 American Chemical 
Society.
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functionalized with hydrophilic and hydrophobic groups. The methyltrimethylcar-
bonate (MTC) family of cyclic carbonates derived from 2,2-bis(methylol)propionic 
acid (bis-MPA) was exploited as a synthetic building block for functional biodegrad-
able monomers. These polycarbonates derived from cyclic carbonates can be prepared 
with a range of pendant functional groups that requires only a single functionaliza-
tion reaction and a simple purification step. Polycarbonates are stable in vitro, while 
they degrade enzymatically in vivo. The LCST of these copolymers varied in the 
range of 36–60°C, depending on the molecular weight of hydrophilic poly(ethylene 
glycol) (PEG) chains, compositions of copolymers and molar ratios of hydrophilic to 
hydrophobic monomers. TRC350-10,30,60, (thermoresponsive polycarbonate block 
copolymer where 10, 30, and 60 refers to degrees of polymerization of MTC-C2, 
MTC-PEG and MTC-C12, respectively) which possessed a LCST of 36°C, was identi-
fied as a useful model polymer with higher Paclitaxel release at the body temperature 
(37°C) as compared to a temperature below the LCST. Ajiro et al. [18] developed a 
thermosensitive biodegradable homopolymer with a poly(trimethylene carbonate) 
(PTMC) backbone and oligoethylene glycol (OEG). The LCST ranged from 31 to 
35°C and was influenced by the molecular weight and polymer concentration.
Some of the other commonly studied thermoresponsive polymers that are focused 
on LCST-typed polymers are typically based on poly(N,N-diethylacrylamide), 
poly(methyl vinyl ether) (PMVE), poly(2-ethyl-2-oxazoline) (PEtOx), poly(ethylene 
oxide)-poly(propylene oxide)-poly(ethylene oxide) (PEO-PPO-PEO), etc.
4.1.2 Ultrasound sensitive
Ultrasound (U/S) is defined as high-frequency pressure waves produced by 
mechanical oscillations in response to an alternating current applied across piezo-
electric materials. Ultrasound devices operate with frequencies from 20 kHz up to 
several gigahertz. Ultrasonic devices are used to detect objects and invisible flaws 
and measure distances. Ultrasound is non-invasive and can penetrate deep into tis-
sue of the body. Low-frequency U/S does not damage or heat the tissues, though it is 
difficult to focus because it produces a larger area of focus. High-frequency U/S can 
be focused on smaller areas. A high-intensity focused ultrasound (HIFU) beam can 
target tumors and can harmlessly penetrate the skin and other tissues. Thus, HIFU 
can be used to treat a variety of tumors.
Ultrasound causes thermal and non-thermal effects on interaction with organic 
tissue. The hyperthermia is due to the absorption of acoustic energy by fluids and 
tissues. Thus, U/S can heat the drug carriers, the drugs, and the treated tissues. 
Hyperthermia induced by the application of U/S is used as an adjuvant in cancer 
chemotherapy and in physical therapy.
The non-thermal effects of U/S are related to cavitating bubbles. Acoustic 
cavitation is the interaction of acoustic waves and gas bubbles. Ultrasound reacts 
with air bubbles and makes them oscillate in response to the negative and positive 
pressure cycles. The air bubbles oscillate and undergo compression and rarefac-
tion at low acoustic amplitudes, and the frequency of their oscillation resonates 
with the frequency of the applied U/S. An increase in acoustic pressure results in 
nonlinear and violent oscillations that ultimately collapse the bubbles (inertial or 
transient cavitation). The collapse of bubbles and resultant high shear force was 
demonstrated to enhance drug uptake by cells (in vivo and in vitro), by temporarily 
increasing the membrane permeability, and can also dismantle nanocapsules, trig-
gering the release of therapeutic payloads [19].
Husseini et al. [20] extensively studied Pluronic P105 micelles and their release 
kinetics in relation to U/S exposure. They studied properties like drug release 
kinetics, pluronic, and drug concentration, the duration of exposure, frequency, 
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intensity, and power density of U/S used. Drug release (doxorubicin and ruboxyl) 
was most efficient at 20 kHz ultrasound and the data suggests an important role of 
transient cavitation in drug release. Zhang et al. [21] developed amphiphilic block 
copolymer PLA-b-PEG encapsulating hydrophobic Nile Red dye. High intensity 
focused ultrasound (HIFU), as a non-contact and remote control approach, can 
trigger the release of the encapsulated cargo. The release behavior of Nile Red can 
be tuned by adjusting the HIFU time, intensity, and location or reactor. An irrevers-
ible release due to the degradation of PLA-b-PEG chain resulting from the transient 
cavitation in the HIFU focal spot was proposed.
2-Tetrahydropyranyl methacrylate (THPMA) is a mechanolabile functional 
group that can hydrolyze in response to U/S exposure. A novel approach was demon-
strated by Xuan et al. [22] to amplify the effect of HIFU on the disassembly of block 
copolymers (BCP). By introducing a small amount of ultrasound-labile functional 
group into the thermosensitive block copolymer, the ultrasound-induced reaction of 
THMPA increased the LCST due to a polarity enhancement. Thus, the BCP becomes 
soluble in water and results in the disassembly without any changes in the solution 
temperature. The validity of this new mechanism was shown by synthesizing and 
investigating a diblock copolymer of PEO112-b-P(MEO2MA189-co-THPMA21). A 
13C NMR spectral analysis provided critical evidence to show that the hydrolysis 
of THPMA groups occurs under HIFU irradiation and that the BCP disassembly 
originates from an increase in the LCST due to the ultrasound-induced conversion 
of hydrophobic comonomer units of THPMA onto hydrophilic methacrylic acid 
(MAA). This general approach of modulating the LCST by ultrasound can be applied 
by further exploring other ultrasound-labile moieties in the block copolymer design.
The ester bonds and disulfide bonds have been known to have U/S responsive-
ness. The disulfide bond has a relatively low dissociation energy (ES–S ~268 kJ mol
−1) 
and longer bond length (lS–S B 2.03 Å) compared with those of the C–C bond (EC–C 
~347 kJ mol−1; lC–C B 1.54 Å) [23]. Li et al. [24] synthesized biodegradable block 
copolymer (PEG-S-S-PLA) containing the central labile disulfide linkage between 
polyethylene glycol (PEG) and poly-L-lactic acid (PLA) segments. When the BCP 
are subjected to HIFU, the labile disulfide bonds are cleaved, and the amphiphilic 
structures are broken, which further leads to the disruption of BCP and the release 
of the encapsulated cargo. HIFU disrupts PEG-S-S-PLA structure because of the 
HIFU-induced site specific degradation of PEG-S-S-PLA.
Tong et al. [25] synthesized pluronic type copolymer PEG-COO-SS-PPG 
containing disulfide and mechanolabile ester bonds at the junction points of PEG 
and PPG blocks. They demonstrated that HIFU caused polymer degradation of the 
BCP and was substantiated by decrease in molecular weight. The molecular weight 
of PEG-COO-SS-PPG decreases with increase in HIFU exposure time. They also 
concluded that the cavitation was the primary reason for the cleavage of ester bonds 
and polymer degradation, and not the U/S-induced thermal effect. The disulfide 
bonds in the copolymer PEG-COO-SS-PPG possessed redox responsive property. 
Thus, the copolymer featured ultrasound and redox dual responsiveness exhibited 
relatively slow redox-induced release behavior and fast HIFU-induced release 
behavior. Ultrasound triggered mechanochemical cleavage occurred preferentially 
at the central ester bond rather than at the disulfide bond.
Wang et al. [26] developed a diblock copolymer composed of poly(ethylene 
oxide) and poly(2-tetrahydropyranyl methacrylate) (PEO-b-PTHPMA) that could 
be hydrolyzed by high-frequency ultrasound (1.1 MHz). HIFU beam could induce 
the hydrolysis reaction of THPMA at room temperature resulting in the cleavage 
of THP groups leading to the formation of carboxylic acid dimers and hydroxyl 
groups. As shown in Figure 3, it was found that upon exposure to a high-intensity 
focused ultrasound (HIFU) beam at room temperature, the pH value decreased 
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over irradiation time. It was also found that with increase in ultrasound power 
output, the pH decrease was more significant, thus demonstrating ultrasound trig-
gered polymer degradation.
Ultrasound triggered drug release has many advantages. It provides the abil-
ity to control the time of drug release from the carrier. This is especially desirable 
when it is required to release the majority of the drug instantly and simultaneously 
to achieve a rapid high and lethal concentration. It would also be prudent to keep 
in mind that whenever ultrasound is utilized, its parameters, such as the power 
density, acoustic frequency, continuous or pulsed U/S, and pulse duration, have to 
be optimized to reach the desired therapeutic effect while minimizing the damage 
to the adjacent health tissues [19].
4.1.3 Light sensitive
Capsules capable of undergoing physical or chemical changes in response to light 
irradiation offer spatiotemporal control over the release of encapsulated therapeutic 
payloads. Chemical and physical processes that can be initiated by light irradiation 
at a specific wavelength can be either reversible or irreversible. These processes 
can involve formation or cleavage of bonds, interconversion of isomers, electro-
static charge switching, and rearrangement of chemical reactions. Light-triggered 
polymeric capsules can be developed by the incorporation of functional groups that 
interact with light which are triggered to disintegrate and release the encapsulated 
payload via light irradiation.
The suitability of these capsules for any biomedical application is dependent on 
the radiation wavelength required. The radiation required should be benign to live 
tissues, exhibit minimal absorption, and interaction with the biological components 
and offer substantial tissue penetration for in vivo applications. X-Rays and γ-rays 
have short wavelengths and possess high energy that would damage normal tissues, 
making them unsuitable for this purpose. UV radiation with its broader wavelength 
and less energy is more suited for developing light-sensitive capsules. Azobenzene 
and spiropyran have been known to undergo UV light-triggered photoisomeriza-
tion. Incorporation of these functional groups into the polymer chain (in the 
backbone or as pendant groups) has helped to develop UV light-triggered capsules.
Under UV light radiation, Azobenzene undergoes photoisomerization from 
apolar trans to polar cis isomeric form. This isomeric transition can be reversed by 
Figure 3. 
(A) Change in pH as a function of ultrasound irradiation time. By repositioning the tube reactor, the location 
of the focal point of the ultrasound beams can be varied (ultrasound power, 200 W). (B) Change in pH as a 
function of ultrasound irradiation time for PEO-b-PTHPMA, using two different ultrasound power outputs. 
Reprinted with permission from Ref. [27]. Copyright 2009 American Chemical Society.
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storage in the dark or by irradiation with visible light. The change in hydrophilic-
ity and the transition from trans to cis conformation can cause disintegration of 
the nanocapsules derived from polymers bearing azobenzene groups, leading to 
payload release.
Xiao et al. [28] developed photo-switchable microcapsules based on host-guest 
interactions between α-cyclodextrin (α-CD) and azobenzene. Confocal laser scan-
ning microscopy was used to observe the photo-dissociation of capsules irradiated 
by UV light, as seen in Figure 3. These microcapsules exhibited controlled release 
behavior. Blasco et al. [29] developed linear-dendritic block copolymers which 
formed polymeric vesicles that are triggered by low intensity UV light, therefore 
limiting the possible toxic effects to organic tissue when exposed to UV radiation. 
The cyano group at the para-position of the azobenzene moiety was substituted by 
an alkyloxy group. This modification was instituted to increase the polarity between 
trans and cis isomers. They demonstrated that structural modification with 4-isobu-
tyloxyazobenzene incorporation facilitated the disruption of azobenzene aggregates 
of the membrane on exposing the vesicles to low intensity UV light when compared 
to its 4-cyanoazobenzene and azobenzene counterparts. Blasco et al. [30] continued 
this work to study the photo-responsiveness of these polymer vesicles with different 
percent of 4-isobutyloxyazobenzene (IBO) and hydrocarbon chains (C18) randomly 
distributed at the periphery of the dendron. Results indicated that by diluting the 
azobenzene content at the periphery of the dendron, the trans-to-cis photoisomer-
ization rate can be substantially accelerated and the light-induced release activity can 
be tuned. Vesicles with a 50/50 IBO/C18 ratio suffered the most significant changes 
upon UV irradiation. Yi and co-workers [31] developed a new class of UV responsive 
polyelectrolyte microcapsules. Upon exposure to UV light, the azobenzene moieties 
in the multilayers self-organized in the form of J aggregates due to the influence of 
polycation [poly(diallyldimethyl ammonium) chloride, (PDADMAC)]. The SEM 
images presented in Figure 4 revealed that the re-orientation of azobenzene within 
Figure 4. 
Snapshots of the photodissociation of microcapsules (A)–(F). The time interval between the snapshots is 
20 min. Scale bar 15 μm. Reprinted with permission from Ref. [19]. Copyright 2011 American Chemical 
Society.
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shell formations led to great damage of capsule integrity, illustrating the progress 
of capsules swelling and their disruption further. After 2 h of UV irradiation, the 
capsule debris was split into needle-like formations. This UV-induced microcapsule 
disruption process was proven to be irreversible.
Among the class of synthetic photoresponsive molecules, spiropyran (SP) 
has been known to possess unique tunability, stability, and fast response time. 
Spiropyran can undergo a reversible transformation from colorless to pink-colored 
merocyanine (MC) upon UV irradiation with a marked increase in the polarity 
associated with the structural conversion from neutral to charge-separated zwit-
terions [32]. This solubility switching of spiropyran from hydrophobic to hydro-
philic can induce the destabilization of polymeric nanocapsules. Moreover, this 
destabilization induces controlled release of model hydrophobic therapeutics by UV 
irradiation. The transition can be reversed by irradiation with visible light. Achilleos 
and coworkers [33] developed water-dispersible nanocapsules based on the forma-
tion of H-type π–π interactions between the merocyanine (MC) isomers within the 
sterically crowded environment of the polymer brushes upon UV irradiation, which 
enables the SP-to-MC isomerization of the photosensitive species. Disruption of 
the nanocapsules can be achieved remotely by applying a harmless trigger such as 
visible-light irradiation.
Besides azobenzene and spiropyran, drug carriers based on cinnamic acid, 
cinnamic ester, and coumarin are also capable of responding to UV irradiation. 
Additionally, 2-diazo-1,2-naphthoquinone (DNQ ), o-nitrobenzyl ester, coumarinyl 
ester, and pyrenylmethyl ester groups, which undergo cleavage, have also been 
explored for the development of UV-radiation-responsive drug carriers [34].
4.2 Endogenous factors
Endogenous stimuli are generated as a result of inherent chemical biological 
pathology in diseased states, such as pH, reactive oxygen species, and elevated 
enzyme levels.
4.2.1 pH sensitive
pH variations between different tissue compartments have been exploited as 
a shining platform for the development of pH-sensitive drug-delivery systems. 
Normal extracellular tissue and systemic blood have a physiological pH of 7.4. 
However, tumor tissues having an abnormally high cell proliferation rate and the 
lack of nutrients leads to a high rate of glycolysis and accumulation of lactic acid, 
which lower the environmental pH by 0.5–1.0 unit as compared to healthy tissues. 
The intracellular organelles, like endosomes and lysosomes, have a more acidic pH 
of 4.0–6.5 [35]. This pH gradient can be exploited as an endogenous stimulus for 
the development of nanocapsules to selectively deliver and activate drug molecules 
while reducing their systemic side-effects. pH-responsive nanocapsules can be 
programmed by functionalizing the polymer backbone with hydrazones, amines, 
acetals, ketals, boronic acid, oximes, etc.
Literature indicated that hydrazone is the most extensively explored pH-respon-
sive chemical bond due to its sharp responsiveness to pH changes. Ganivada et al. 
[36] synthesized a newly designed biodegradable copolymer (PVLPEG-PVLDOXI-
PCL-PHOS-Fe3O4) that can be used as a nanocapsule. The magnetic nature of Fe3O4 
is expected to behave as a smart nanocarrier for both magnetic resonance imaging 
(MRI) as well as efficient sustained delivery vehicle for doxorubicin. The acylhydra-
zine linker helps to release the drug under mild acidic conditions. Wang et al. [37] 
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developed a biodegradable endosomal pH-sensitive polymeric prodrug based on 
poly(5-methyl-5-allyloxycarbonyl-1,3-dioxan-2-one)-graft-12-acryloyloxy dodecyl 
phosphorylcholine (PMAC-graft-ADPC). Doxorubicin was conjugated to the poly-
mer through hydrazone bonds. In vitro drug release studies showed that the release 
of doxorubicin was faster at endosomal pH (pH = 5.0) than at normal physiological 
environment (pH = 7.4), as shown in Figure 5.
Acetal is another acid-labile functional group that can be wielded to design 
smart polymeric nanocapsules. Tonhauser et al. [38] developed long chain 
branched and hyperbranched polyether polyols by copolymerization of an acetal-
containing inimer, namely, 1-(glycidyloxy)ethyl ethylene glycol ether (GEGE) 
with ethylene oxide and glycidol. Owing to the presence of acetal group, a strong 
pH-dependence of the degradation kinetics was observed. At pH 4.5, t1/2 (half-
life) is approximately 76 h, while at pH 4, t1/2 is almost one-third of this value 
with 26 h. Also, since no degradation was observed at pH 7 or higher, storage 
stability was guaranteed. Hu et al. [39] designed a series of well-defined three-
armed star-block copolymers containing poly(ethylene glycol) monomethyl ether 
(mPEG) and poly(Ɛ-caprolactone) blocks linked with acid-cleavable acetal groups 
to demonstrate the pH-dependent release of doxorubicin. Tomlinson et al. [40] 
proved that the pH responsiveness of acetal-labile polymer was due to polymer 
degradation. It was substantiated by a pH-dependent decrease in molecular weight 
at pH 7.4, 6.5, and 5.5.
β-Carboxylic amide is another acid-sensitive functional group that can be 
included as a pendant chain to incorporate its acid-sensitivity to the parent polymer 
chain. β-Carboxylic amides functionalized polymer chains are negatively charged 
and stable at neutral pH, but when the pH is decreased to 6, they quickly become 
positively charged due to the hydrolysis of β-carboxylic amides in acidic condition. 
After hydrolysis, the β-carboxylic amides form cationic primary amines. This charge 
reversal or charge conversion can have two main effects. In 1997, Behr [41] proposed 
the “proton-sponge” hypothesis describing that unprotonated amines can absorb pro-
tons as they are pumped into the lysosome, resulting in more protons being pumped 
in leading to an increased influx of chlorine ions and water. This increases endosomal 
pH. A combination of osmotic swelling and swelling of the amine-functionalized 
polymer triggers endosomal escape, with subsequent release of its contents into the 
cytoplasm because of repulsion between protonated amine groups, which causes 
the rupture of the lysosomal membrane. Secondly, β-carboxylic amides modified 
Figure 5. 
Time-dependent cumulative release of doxorubicin from PPC-Hyd-DOX-DA NPs at different pH values. 
Reprinted with permission from Ref. [33]. Copyright 2011 American Chemical Society.
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polymer can exploit its negative charge interaction with cationic drugs like doxoru-
bicin to achieve high drug-loading capacity and efficiency. The pH induces charge 
reversal in acidic condition, and generates a repulsive electrostatic force between 
positively charged amines and cationic drugs, leading to accelerated drug release. 
Quadir et al. [42] showed that PEG–polypeptide copolymers with amine pendant 
chains can be utilized as a pH-responsive drug-delivery vehicle. These nanosized 
vesicles were proved to be stable platforms for drug delivery that can successfully 
localize in solid tumors and release doxorubicin, mediated by the enhanced perme-
ation, and retention effect by lowering the pH of the tumor microenvironment.
The pH difference between healthy and disease tissue, and between extracellular 
and intracellular compartments, has been exploited to fabricate the pH-responsive 
polymer nanocapsules for controlled drug release. This field is the target of exten-
sive investigations being done worldwide.
4.2.2 Reactive oxygen species sensitive
Reactive oxygen species (ROS) are partially reduced chemically reactive 
metabolites of oxygen. These include superoxide anion, hydroxyl radical, hydrogen 
peroxide, peroxynitrite, and hypochlorous acid. ROS have important roles in cell 
signaling and homeostasis. However, high levels in certain pathological conditions 
can damage the cells by causing oxidations of lipids, proteins, and DNA. These have 
also been known to cause oxidative deactivation of specific enzymes by oxidation 
of co-factors. This is known as oxidative stress. Elevated levels of ROS have been 
implicated in a number of pathological conditions, including aging, male infertility, 
inflammation, infections, cancer, atherosclerosis, reperfusion injury, and diabetes 
[43]. This has sparked a lot of interest into finding ways to create ROS-eliminating 
strategies. This has been achieved by two mechanisms.
The first mechanism involves a phase transition of the polymer backbone from 
hydrophobic to hydrophilic, thus making the capsule wall material soluble in solu-
tion and release the therapeutic payload. Sulfides and selenides are the two func-
tional groups, when subjected to ROS, increase their solubility in water. Ma et al. 
[27] synthesized a diselenide-containing block copolymer and both the oxidizing 
and reducing groups were shown to have the capability to destroy Se-Se bonds. 
Poole et al. [44] developed ROS-responsive poly(propylene sulfide) (PPS) micro-
spheres, which were successfully utilized for encapsulation and sustained delivery 
of curcumin in the diabetic mouse hind limb ischemia model of peripheral arterial 
disease. The PPS microspheres were biocompatible, improved cell survival under 
exogenous oxidative stress and reduced ROS levels both in vitro and in vivo.
The second mechanism involves the physical degradation of polymer backbone 
in response to ROS. Functional groups like boronic-esters, thioketals, and prolines 
have been proven to be ROS sensitive. Zhang et al. [45] synthesized 4-phenylboronic 
acid pinacol ester (PBAP) chemically conjugated onto hydroxyl groups of β-CD 
to synthesize oxidatively responsive β-cyclodextrin. ROS-sensitivity and superior 
biocompatibility of this boronic-ester functionalized cyclodextrin were validated 
via extensive in vitro and in vivo studies. Lee et al. [46] developed a ROS-degradable 
scaffold by crosslinking PCL with a ROS-degradable oligoproline peptide, KP7K, 
which was further investigated in an in vivo model for long-term tissue engineering 
applications. The KP7K-crosslinked polymer scaffolds underwent significant surface 
degradation in response to ROS.
In 2010, Wilson et al. [47] developed thioketal nanoparticles formulated via 
a polymer, poly-(1,4-phenyleneacetone dimethylene thioketal), that degraded 
selectively in response to ROS. Thioketal bonds were found to be stable to acid-, 
base-, and protease-catalyzed polymer degradation. In a murine model of ulcerative 
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colitis, orally administered thioketal nanoparticles, loaded with siRNA against 
the proinflammatory cytokine TNF-α, remained stable in the harsh environment 
of the gastrointestinal tract, protecting TNF–siRNA and preventing its release to 
non-inflamed mucosal tissues. However, at sites of intestinal inflammation, where 
infiltrating phagocytes produce unusually high levels of ROS, the thioketal bond 
crosslinked polymer degrades thus releasing TNF-siRNA to the site of inflamma-
tion. This led to controlled gene silencing to curtail TNF-mRNA levels in the colon 
and protect the mice from ulcerative colitis.
4.2.3 Enzyme sensitive
Enzymes are the key biological catalysts that play a vital role in all chemical, 
metabolical, and biological processes serving as the prime protagonists in the 
chemistry of living organisms at a molecular level. As their presence and activities 
are essential in maintaining the physiological homeostasis, enzyme dysregulation 
is associated with many diseases and pathological disorders, such as cancer, cardio-
vascular disease, inflammation, osteoarthritis, Alzheimer’s disease, inborn errors 
of metabolism, etc. Therefore, altered expression level of specific enzymes can be 
exploited as a pristine biological trigger to achieve enzyme-mediated biomaterial 
responses and controlled release of biomolecules at the desired sites. Compared to 
typical catalyzed or non-catalyzed chemical reactions involved in polymer synthe-
sis, enzyme-catalyzed reactions exhibit superior advantages, such as high selectivity 
and substrate specificity. These reactions can be conducted under quite mild condi-
tion (37°C, aqueous media, typically neutral or slightly acidic and alkaline pH). 
Another advantage is that enzyme-catalyzed reactions can be conducted in vitro.
Azobenzene is an artificial structural moiety that can be used to fabricate 
azoreductase-sensitive nanocapsules. The enzyme azoreductase is produced by 
microbial flora specifically present in the colon of the human intestine which 
makes it an elegant stimulus to create colon-specific drug-delivery systems. Rao 
et al. [48] developed an amphiphilic diblock copolymer with an azobenzene 
linkage introduced as an artificial enzyme active site at the junction of the diblock 
copolymer. The authors documented the enzymatic dissociation of the copolymer 
connection which released the two polymer segments following introduction of the 
enzyme azoreductase, in the presence of coenzyme Dihydronicotinamide-adenine 
dinucleotide phosphate (NADPH), leading to the cleavage of the azobenzene-based 
block copolymer linkage. The authors thus established the potential applications of 
azobenzene linkages in the realm of colon-specific drug-delivery systems.
Gelatinase is a mixture of two types of matrix metalloproteinase (MMP) enzymes 
that is highly expressed in tumor tissues. Dong et al. [49] developed a pH and 
enzyme-responsive complex composed of doxorubicin, CpG DNA fragments, cat-
ionic gelatin, and pH-sensitive alginate. Since gelatinase is relatively highly expressed 
in liver, a PEGylated pH-responsive alginate was introduced to reduce the liver 
accumulation of doxorubicin and thus attenuate its hepatotoxicity. The gelatinase and 
DNase present in high concentration in the cytoplasm of tumor cells helped to dis-
sociate the cationic gelatin and CpG DNA fragments and enhanced the drug release.
5. Future Prospects and Challenges
Wall materials are already playing an important role in the development of micro-/
nanoformulations, which have been applied as drug-delivery systems. These drug-
delivery systems have greater potential for many applications, including anti-tumor 
therapy, gene therapy, AIDS-therapy, radiotherapy, delivery of proteins, antibiotics, 
Microencapsulation - Processes, Technologies and Industrial Applications
16
© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
Author details
Shaluah Vijeth, Geetha B. Heggannavar, Mahadevappa Y. Kariduraganavar*
Department of Chemistry, Karnatak University, Dharwad, India
*Address all correspondence to: mahadevappayk@gmail.com
virostatics, vaccines, and as vesicles to cross the blood-brain barrier. Nanocapsules par-
ticularly provide massive advantages regarding drug targeting, delivery, and release. 
With their additional potential to combine diagnosis and therapy, they emerge as one 
of the major tools in nanomedicines. The major challenges are to improve their stability 
in a biological environment, to mediate the biodistribution of active compounds, 
improve drug loading, and establish greater interaction with the biological barriers. 
The cytotoxicity and the degradation products of the formulations developed from 
the wall materials remain a major problem. Thus, improvements in biocompatibility 
are the main concern of future research. These challenges can be suitably addressed by 
developing newer polymeric wall materials, which can be of better biocompatibility 
with the biological environment. Simultaneously, molecular modeling study would 
greatly contribute in understanding the interaction between the wall materials and 
drug, and this in turn with the biological environment. Finally, the success of this is 
largely dependent on the efforts of scientists, physicians, and engineers.
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